IDH1 and glioblastoma: For example, a recent transcriptome analysis of long-term GBM survivors showed that concurrent gain of chromosomes 19 and 20 (hereafter referred to as 19/20 co-gain) is a positive prognostic factor in GBMs that lack the IDH mutation [19].